Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369485 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder
A NA study, sponsored by Ethicon Endo-Surgery.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT01369485 is a NA study that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 163 participants.
The verdict
NCT01369485, a NA study, has completed, sponsored by Ethicon Endo-Surgery.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the change from baseline between the active and sham treatment groups in the treatment of urgency (urinary) incontinence episodes (leaks).
Interventions
- DEVICE (VERV™ System)
- DEVICE Sham version of (VERV™ System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01369485
The ClinicalTrials.gov registry entry for NCT01369485 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which (VERV™ System) is the first listed.
NCT01369485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01369485 about?
NCT01369485 is a clinical study titled "Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder". The purpose of this study is to evaluate the change from baseline between the active and sham treatment groups in the treatment of urgency (urinary) incontinence episodes (leaks).
What is the current status of trial NCT01369485?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2011-06. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01369485?
The interventions under investigation include: (VERV™ System) (DEVICE), Sham version of (VERV™ System) (DEVICE).
Who is sponsoring clinical trial NCT01369485?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.